10th US-India BioPharma & Healthcare Summit, Thursday, June 2, 2016, Marriott Cambridge, MA
Guest Reporter of this Event on @pharmaceuticalintelligence.com:
Karun Rishi
President
USA-India Chamber of Commerce
Tel: 781 586-1212
Twitter @ USAIC handle for the Summit #USAIC16
REGISTRATION Online
https://s01.123signup.com/servlet/SignUpMember?PG=1529661182300&P=15296611911420195500
About Us Structure Current Events Past Events Councils Policy & Reports Photo Gallery Awards Membership Media Coverage Internship/Volunteers Legal Contact Us The USA-India Chamber of Commerce mission is to provide a pro-active & professional platform for high ranking policy makers, senior business executives, academicians, and investors in the United States and India to network, facilitate and promote trade, investments & economic cooperation. USAIC’s four point agenda is: Trade, Investment, Policy and Advocacy. Search 10th US-India BioPharma & Healthcare Summit, Thursday, June 2, 2016, Marriott Cambridge
SOURCE
http://usaindiachamber.org/current-events.shtml
SPEAKERS
http://usaindiachamber.org/current-events.shtml
AGENDA
Master of Ceremonies (Emcee)– Andrew Plump, MD, PhD; Chief Medical & Scientific Officer, Takeda Pharmaceuticals
US-India BioPharma & Healthcare Summit
Date: Thursday, June 2, 2016
Location: Grand Ballroom, Marriott Cambridge, Massachusetts, USA
* Speakers and Timings subject to change
Time | Topic |
8-45 AM – 9-15 AM | Registration and Networking |
9-15 AM – 9-20 AM | Welcome address by Karun Rishi, President, USA-India Chamber of Commerce |
9-20 AM – 9-30 AM | Opening comments by Master of Ceremonies – Dr Andrew Plump, Chief Medical & Scientific Officer, Member of the Board of Directors, Takeda Pharmaceuticals |
9-30 AM – 10-00 AM | India Regulatory and Clinical Research Update* K.L. Sharma, IAS, Joint Secretary, Ministry of Health and Family Welfare, India Dr G. N. Singh, Drug Controller General of India, Central Drugs Standard Control Organization |
10-00 AM – 10-50 AM | Panel Discussion: Neurodegenerative diseases- Matters of the mind |
10-50 AM – 11-20 AM | Fireside Chat with Dr David Meeker, Head, Sanofi Genzyme and Dilip Shanghvi, Managing Director, Sun Pharmaceutical Industries moderated by Dr Martin Mackay, Executive Vice President, Global Head of Research and Development, Alexion |
11-20 AM -11-50 AM | Networking & Tea Break |
11-50 AM – 12-40 PM | Panel Discussion: Drug Discovery and Collaborative Research: The path forward |
12-40 PM – 1-10 PM | Fireside Chat with Dr Griffin Rodgers, Director, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH moderated by Dr William Chin, Executive Vice President, PhRMA |
1-10 PM – 2-40 PM | Luncheon Panel Discussion: Oncology- Immuno-oncology, data analytics and value platforms – the new world order |
2-40 PM – 3-15 PM | Networking & Tea Break |
3-15 PM – 4-05 PM | Panel Discussion: Cardiovascular and Metabolic Diseases- Matters of the heart and the body |
4-05 PM – 4-55 PM | Panel Discussion: Regulatory Policies to foster R&D Innovation |
4-55 PM – 5-00 PM | Closing Remarks |
5-00 PM – 6-30 PM | Cocktails & Networking Reception |
SOURCE
Leave a Reply